Nemaura Medical Inc. (NMRD)
OTCMKTS: NMRD · Delayed Price · USD
0.105
+0.073 (229.06%)
Jul 18, 2024, 4:00 PM EDT - Market closed
Nemaura Medical Employees
Nemaura Medical had 36 employees as of March 31, 2023. The number of employees increased by 4 or 12.50% compared to the previous year.
Employees
36
Change (1Y)
4
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$174,905
Market Cap
4.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
NMRD News
- 7 months ago - Important Update on Listing Status and Strategic Direction - GlobeNewsWire
- 7 months ago - Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - GlobeNewsWire
- 8 months ago - Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth - GlobeNewsWire
- 8 months ago - Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs - GlobeNewsWire
- 8 months ago - Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 10 months ago - Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. - GlobeNewsWire
- 11 months ago - Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference - GlobeNewsWire
- 11 months ago - Nemaura Medical Provides Update on Nasdaq Compliance Status and Process - GlobeNewsWire